ICM
NABL icon

Invenomic Capital Management’s N-able NABL Stock Holding History

Invenomic Capital Management’s Portfolio NABL Stock Details NABL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-510,155
Closed -$4.13M – 169
2025
Q2 		$4.13M Sell
510,155
-81,078
-14% -$605K 0.23% 108
2025
Q1 		$4.19M Buy
+591,233
New +$5.26M 0.21% 122

Other funds holding NABL

SLG
Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return
TB
Thoma Bravo Chicago, Illinois $7.28B AUM 35.55% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sunriver Management Greenwich, Connecticut $637M AUM 2.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
AP
AlpInvest Partners Amsterdam, Netherlands $59.9M AUM 0.03% 1-Year Est. Return

Invenomic Capital Management's NABL Position: Q3 2025 in Review

Invenomic Capital Management sold out of N-able (NABL) in Q3 2025, closing a stake of 510,155 shares — an estimated $4.13M sold.

Invenomic Capital Management first reported a position in NABL in Q1 2025 and held it in 2 quarters. The position peaked at $4.19M in Q1 2025. 202 funds tracked by Wall St. Rank hold NABL as of Q3 2025.

  • Invenomic Capital Management reported no remaining N-able position as of Q3 2025 after selling out during the quarter.
  • Invenomic Capital Management sold 510,155 N-able shares in Q3 2025, an estimated $4.13M.
  • Invenomic Capital Management first reported a position in N-able in Q1 2025 and held it in 2 quarters.
  • Invenomic Capital Management's N-able position peaked at $4.19M in Q1 2025.
  • 202 funds tracked by Wall St. Rank held N-able as of Q3 2025.

Based on Invenomic Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.